By Nadia Dreid ( February 28, 2023, 10:28 PM EST) -- Buyers of a generic epilepsy drug aren't so numerous that they must be allowed to band together in a class action rather than joining their suits together traditionally, said a New Jersey federal judge who has refused to certify their class in an antitrust suit against drugmakers GlaxoSmithKline and Teva Pharmaceuticals....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.